Aegon completes sale of 50% stake in joint venture with Liberbank to Unicaja Banco
About
| Contacts | |
| Media relations | Investor relations |
| Dick Schiethart |
|
| +31(0) 6 2288 9925 | +31(0) 70 344 8028 |
| [email protected] | [email protected] |
Forward-looking statements
The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, could, is confident, will, and similar expressions as they relate to
- Unexpected delays, difficulties, and expenses in executing against our environmental, climate, diversity and inclusion or other “ESG” targets, goals and commitments, and changes in laws or regulations affecting us, such as changes in data privacy, environmental, safety and health laws;
- Changes in general economic and/or governmental conditions, particularly in
the United States ,the Netherlands and theUnited Kingdom ; - Civil unrest, (geo-) political tensions, military action or other instability in a country or geographic region;
- Changes in the performance of financial markets, including emerging markets, such as with regard to:
- The frequency and severity of defaults by issuers in Aegon’s fixed income investment portfolios;
- The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities
Aegon holds; - The effects of declining creditworthiness of certain public sector securities and the resulting decline in the value of government exposure that
Aegon holds;
- Changes in the performance of Aegon’s investment portfolio and decline in ratings of Aegon’s counterparties;
- Lowering of one or more of Aegon’s debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegon’s ability to raise capital and on its liquidity and financial condition;
- Lowering of one or more of insurer financial strength ratings of Aegon’s insurance subsidiaries and the adverse impact such action may have on the written premium, policy retention, profitability and liquidity of its insurance subsidiaries;
- The effect of the European Union’s Solvency II requirements and other regulations in other jurisdictions affecting the capital
Aegon is required to maintain; - Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels;
- Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates;
- Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness;
- Increasing levels of competition in
the United States ,the Netherlands , theUnited Kingdom and emerging markets; - Catastrophic events, either manmade or by nature, including by way of example acts of God, acts of terrorism, acts of war and pandemics, could result in material losses and significantly interrupt Aegon’s business;
- The frequency and severity of insured loss events;
- Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the profitability of Aegon’s insurance products;
- Aegon’s projected results are highly sensitive to complex mathematical models of financial markets, mortality, longevity, and other dynamic systems subject to shocks and unpredictable volatility. Should assumptions to these models later prove incorrect, or should errors in those models escape the controls in place to detect them, future performance will vary from projected results;
- Reinsurers to whom
Aegon has ceded significant underwriting risks may fail to meet their obligations; - Changes in customer behavior and public opinion in general related to, among other things, the type of products
Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations; - Customer responsiveness to both new products and distribution channels;
- As Aegon’s operations support complex transactions and are highly dependent on the proper functioning of information technology, operational risks such as system disruptions or failures, security or data privacy breaches, cyberattacks, human error, failure to safeguard personally identifiable information, changes in operational practices or inadequate controls including with respect to third parties with which we do business may disrupt Aegon’s business, damage its reputation and adversely affect its results of operations, financial condition and cash flows;
- The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including Aegon’s ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions;
- Aegon’s failure to achieve anticipated levels of earnings or operational efficiencies, as well as other management initiatives related to cost savings,
Cash Capital at Holding, gross financial leverage and free cash flow; - Changes in the policies of central banks and/or governments;
- Litigation or regulatory action that could require
Aegon to pay significant damages or change the wayAegon does business; - Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegon’s products;
- Consequences of an actual or potential break-up of the European monetary union in whole or in part, or the exit of the
United Kingdom from theEuropean Union and potential consequences if otherEuropean Union countries leave theEuropean Union ; - Changes in laws and regulations, particularly those affecting Aegon’s operations’ ability to hire and retain key personnel, taxation of
Aegon companies, the productsAegon sells, and the attractiveness of certain products to its consumers; - Regulatory changes relating to the pensions, investment, and insurance industries in the jurisdictions in which
Aegon operates; - Standard setting initiatives of supranational standard setting bodies such as the Financial Stability Board and the
International Association of Insurance Supervisors or changes to such standards that may have an impact on regional (such as EU), national or US federal or state level financial regulation or the application thereof toAegon , including the designation ofAegon by the Financial Stability Board as a Global Systemically Important Insurer (G-SII); and - Changes in accounting regulations and policies or a change by
Aegon in applying such regulations and policies, voluntarily or otherwise, which may affect Aegon’s reported results, shareholders’ equity or regulatory capital adequacy levels.
This document contains information that qualifies, or may qualify, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation (596/2014). Further details of potential risks and uncertainties affecting
Attachment
Source:



Seniors Save When Switching Medicare Drug Plans Reports AAMSI
Ping An Ranks 5th Among Global Insurance Companies, Tops China's Financial Companies in Forbes' World's Best Employers 2022
Advisor News
- Study asks: How do different generations approach retirement?
- LTC: A critical component of retirement planning
- Middle-class households face worsening cost pressures
- Metlife study finds less than half of US workforce holistically healthy
- Invigorating client relationships with AI coaching
More Advisor NewsAnnuity News
- Trademark Application for “EMPOWER MY WEALTH” Filed by Great-West Life & Annuity Insurance Company: Great-West Life & Annuity Insurance Company
- Conning says insurers’ success in 2026 will depend on ‘strategic adaptation’
- The structural rise of structured products
- How next-gen pricing tech can help insurers offer better annuity products
- Continental General Acquires Block of Life Insurance, Annuity and Health Policies from State Guaranty Associations
More Annuity NewsHealth/Employee Benefits News
- RISING EMPLOYER-SPONSORED HEALTH INSURANCE RATES
- New Managed Care Study Findings Have Been Reported by G. Martin Reinhart and Co-Researchers (Psychiatric Medication Prescribing by Nurse Practitioners and Physician Associates for Medicare Beneficiaries): Managed Care
- Data on Managed Care Reported by Researchers at American Dental Association (Early association of expanded Medicare dental benefits to dentist billing in Medicare): Managed Care
- Researchers to study universal health care, as Coloradans face $1 billion in medical debt
- Veteran speaks out on veterans mail-order drug bill
More Health/Employee Benefits NewsLife Insurance News